---
title: "Genezen and Atsena form strategic manufacturing partnership in Jan 2026. Genezen is a gene therapy CDMO, Atsena is a clinical gene therapy company."
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/273090471.md"
description: "On January 20, 2026, Genezen, a top gene therapy Contract Development and Manufacturing Organization (CDMO) based in Lexington, Massachusetts, and Atsena Therapeutics, a clinical-stage gene therapy company from Durham, North Carolina, announced a collaboration. Atsena Therapeutics aims to harness the transformative potential of genetic treatments. The partnership allows Genezen to provide its expertise in gene therapy manufacturing to support Atsena Therapeutics. This collaboration signifies a significant step forward in advancing gene therapy research and development efforts."
datetime: "2026-01-20T13:05:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/273090471.md)
  - [en](https://longbridge.com/en/news/273090471.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/273090471.md)
---

# Genezen and Atsena form strategic manufacturing partnership in Jan 2026. Genezen is a gene therapy CDMO, Atsena is a clinical gene therapy company.

On January 20, 2026, Genezen, a top gene therapy Contract Development and Manufacturing Organization (CDMO) based in Lexington, Massachusetts, and Atsena Therapeutics, a clinical-stage gene therapy company from Durham, North Carolina, announced a collaboration. Atsena Therapeutics aims to harness the transformative potential of genetic treatments. The partnership allows Genezen to provide its expertise in gene therapy manufacturing to support Atsena Therapeutics. This collaboration signifies a significant step forward in advancing gene therapy research and development efforts.

### Related Stocks

- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [NBSE.ESC.US](https://longbridge.com/en/quote/NBSE.ESC.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [IHI.US](https://longbridge.com/en/quote/IHI.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [ATRX.US](https://longbridge.com/en/quote/ATRX.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)

## Related News & Research

- [14:05 ETLupin Receives Tentative Approval from U.S. FDA for Revefenacin Inhalation Solution](https://longbridge.com/en/news/286805922.md)
- [Acrivon Therapeutics, Inc. (ACRV) Receives a Buy from Oppenheimer](https://longbridge.com/en/news/286428001.md)
- [Relay drug shows early promise against rare blood vessel diseases](https://longbridge.com/en/news/287094432.md)
- [Radnor Capital Management LLC Has $1.65 Million Stock Holdings in West Pharmaceutical Services, Inc. $WST](https://longbridge.com/en/news/286893528.md)
- [Resona Asset Management Co. Ltd. Cuts Position in Danaher Corporation $DHR](https://longbridge.com/en/news/286897088.md)